Skip to content
Peptigraph home

Is SLU-PP-332 Legal? FDA, Compounding and WADA Status

SLU-PP-332's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medical review pendingERR agonist (not a peptide)Updated
FDA status
Not approved
research chemical
PCAC vote
Not reviewed
not on the Jul 2026 PCAC agenda
WADA
Unclear
Not named on the 2026 list
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

Not FDA approved · research chemical

No. SLU-PP-332 is not FDA approved for any use.

SLU-PP-332: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "SLU-PP-332" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

No FDA, advisory-committee or WADA action specific to SLU-PP-332 found in our records (checked 2 Oct 2026).
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.

Sport and drug testing

WADA status unclear

SLU-PP-332 is not named. S4.4 lists AMPK activators, PPAR-delta agonists and Rev-erb agonists; SLU-PP-332 is an ERR agonist, which the list does not mention. This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

SLU-PP-332: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "SLU-PP-332" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "SLU-PP-332" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
AustraliaNo approved product foundNo approved product found in an ARTG search for "SLU-PP-332" on 2 Oct 2026.tga.gov.auchecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

No approved product found

The Drugs@FDA search was run with the ingredient name SLU-PP-332 and returned an error response.[2]

The Drugs@FDA response uses a not-found code for the ingredient.[2]

The Health Canada Drug Product Database returned zero active-ingredient records for SLU-PP-332.[4]

The UK emc compendium search for SLU-PP-332 returned no results.[3]

The EMA export of centrally authorised medicines recorded no matching rows for this name.[6]

The Australian ARTG search returned no matching results.[5]

How the anti-doping list treats it

WADA's catch-all class S0 prohibits substances with no current approval by any governmental regulatory health authority for human therapeutic use; SLU-PP-332 is not named on the list, and whether S0 applies depends on approval status.[1]

A doping-control paper states that WADA prohibits exercise mimetics and metabolic modulators and describes SLU-PP-332 as a small synthetic ERR agonist.[7]

Common questions

Is SLU-PP-332 FDA approved?

No: the Drugs@FDA search by active ingredient returned no matches.[2]

Is SLU-PP-332 legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is SLU-PP-332 banned by WADA?

It is unclear. SLU-PP-332 is not named. S4.4 lists AMPK activators, PPAR-delta agonists and Rev-erb agonists; SLU-PP-332 is an ERR agonist, which the list does not mention. This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

Is SLU-PP-332 legal?

It has no approval in the regulators searched, and the doping-control paper says WADA prohibits exercise mimetics in sports.[7]

More on SLU-PP-332

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "SLU-PP-332" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "SLU-PP-332" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  4. 4Canada: No product found in a Health Canada Drug Product Database search for ingredient "SLU-PP-332" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  5. 5Australia: No approved product found in an ARTG search for "SLU-PP-332" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
  6. 6EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
  7. 7Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.Drug testing and analysis · 2026PMID 41688415Accessed 2 Oct 2026

Found an error? Report a correction.